JDRF and Novo Nordisk establish R&D collaboration in type 1 diabetes
To address the underlying autoimmune process that is central to type 1 diabetes, JDRF in the USA and Novo Nordisk are partnering to discover and
To address the underlying autoimmune process that is central to type 1 diabetes, JDRF in the USA and Novo Nordisk are partnering to discover and
Novo Nordisk’s new variety of long-lasting insulin, insulin degludec, reduces low blood sugars while improving overall control Novo Nordisk’s new variety of long-lasting insulin, insulin
Our latest issue is out! Click on the pic to read all about whether coffee really can make your sugars rise. And that’s just the
The NovoPen Echo is Novo Nordisk’s latest insulin pen and it’s especially designed to meet the needs of children. not only does it deliver in
NovoTwist needle has a novel bayonet fitting that allows simple ‘just twist’ attachment and detachment to compatible pens. Conventional screw thread needles can be difficult
Novo Nordisk’s FlexTouch is the latest advancement in pre-filled insulin pens. Designed to help improve patients’ experience of daily insulin injections, the unique design of
For pen users who prefer not to see the needle, the NovoPen PenMate is just what they need to make pen injections less stressful. The
Regarding the discontinuation of Novo Nordisk’s Mixtard30, only the Mixtard30 InnoLet is being discontinued — the InnoLet device will still be available with two other
Novo Nordisk has introduced NovoDose, a mobile insulin dosing guide for physicians to look up dosing guidelines and blood glucose goals for their patients with
From a talk given at the UK launch of the new Type 2 treatment given by Viggo Birch, vice president and managing director, Novo Nordisk